Company Filing History:
Years Active: 2020-2022
Title: Suneel Singh: Innovator in Retinoid Research
Introduction
Suneel Singh is a notable inventor based in Kingston, Canada. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit CYP26 enzymes. His work is crucial for advancing treatments for diseases responsive to retinoids.
Latest Patents
Suneel Singh holds 2 patents related to his innovative research. His latest patents include "Compounds and methods for inhibiting CYP26 enzymes." These compounds are designed to inhibit retinoic acid inducible P450 (CYP26) enzymes, which are essential for treating diseases that respond to retinoids. The compounds exhibit retinoid activity and are resistant to CYP26-mediated catabolism, making them valuable in therapeutic applications.
Career Highlights
Suneel Singh is affiliated with Queen's University at Kingston, where he conducts his research. His work has garnered attention for its potential impact on medical treatments and drug development. His innovative approach to inhibiting CYP26 enzymes showcases his expertise in the field.
Collaborations
Suneel has collaborated with notable colleagues, including Donald Andrew Cameron and Martin Petkovich. These collaborations have further enriched his research and contributed to advancements in the understanding of retinoid-responsive diseases.
Conclusion
Suneel Singh's contributions to the field of biochemistry, particularly in the development of CYP26 inhibitors, highlight his role as an innovator. His work at Queen's University at Kingston continues to pave the way for new therapeutic strategies.